Key takeaways from concall :
(1) Agri contributed 196 cr. while CSM contributed 208 cr. in Q1FY14.
(2) Quarterly Runrate for CSM expected to be 200 cr. + for all subsequent quarters.
(3) Upgraded yearly growth guidance for CSM segment from 25 % earlier to 33 %.
(4) Yearly growth guidance for Agri segment put at 20-25 % for FY14.
(6) Orger-book for CSM segment stands at USD 307 mn.
(5) Jambusar plant contributed 30 cr. to Q1FY14 revenues and is expected to contribute ~100-120 cr. for FY14.
(6) Inlicensed products contributed ~60 % to Agri segment revenues.
(7) Q2FY14is shaping up better and management expects a positive growth over the higher base of Q2FY13.
(8) Inventories stands at 220 cr. ; Receivables at 370 cr. and Payables at 240 cr. whereas Gross Debt stands at 151 cr. with Cash & Cash Equivalents standing at 150 cr…
View post concall :
CSM segment is set to touch ~830 cr. revenue mark for FY14 which necessitates a revisit to our FY14e numbers. Since Agri segment is dependent on spread of monsoons and occurence of pest incidence we will wait for Q2FY14 numbers to revisit our FY14e Agri segment numbers. To sum-up, we revise our FY14e revenues upwards from 1380 cr. to 1460 cr. and FY14e EBITDA from 232 cr. to 251 cr. which takes us to revision in PAT from 129 cr. to 138 cr…
These are most conservative estimates and it is most likely that company will be able to easily surpass the anticiapated numbers. This is because, this is the first time we are witnessing strongest undercurrent in CSM segment which is very healthy for financials of the company. Business model of CSM is such that once a strong undercurrent sets in, it sustains for long as majority of the orders are from patented assignments. It is most likely that by Q3FY14 we will hear from the company on second phase of Jambusar project.
Second and most important point to note now is that, management is now guiding for considerable reduction in already low debt going forward as it expects considerable free cash flow generation from the business. This will be great news for shareholders as it will mean higher dividend payout as also higher net profitability which will result in higher valuations on the bourses.
To sum up in short, the results of Q1FY14 are exceptional by any standards and they can’t remain ignored by the markets for too long. One more good quarter ( only good and not exceptional ) and we will see PI stock get rerated significantly on the bourses. On the Q1FY14 declared results, PI’s immediate trading range deserves to shift upwards to 158-170 from current 122-140 which should happen as soon as markets settle slightly.
Rgds.